More on CI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+5.4% Growth)
- Ratings (6.9 Score)
- Holders
- Dividends (2.2% Yield)
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (7/30/26)
- M&A (12/31/18 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

CI Income Statement

Click line-items for a historical chart and %
Premiums and fees
Net investment income 282M
Mail order pharmacy revenues 762M
Other revenues 1.16B
Other-than-temporary impairments on debt securities, net -1M
Other realized investment gains 76M
Total realized investment gains before income taxes
Total revenues 9.88B
Health Care medical claims expense 4.69B
Other benefit expenses 1.34B
Mail order pharmacy cost of goods sold 638M
GMIB fair value loss
Other operating expenses
Total benefits and expenses 9.14B
Income before Income Taxes
Current 210M
Deferred 80M
Total taxes 290M
Net Income 452M
Less: Net Income Attributable to Noncontrolling Interest -4M
Shareholders' Net Income
Shareholders' net income 1.78
Shareholders' net income 1.76
Dividends Declared Per Share 0